Aktsia BB Biotech 2nd Line Ord Shs (BBZA) hind ja uudised – Google Finance

AvalehtBBZA • FRA

BB Biotech 2nd Line Ord Shs

40,15 €

15. jaan, 22:15:00 GMT +1 · EUR · FRA · Välistus

HLB Inc

74 700,00 ₩

0283005,92%

Hualan Biological Engineering Inc

15,92 ¥

0020070,063%

Sichuan Kelun-Biotech Biophrmctcl Co Ltd

161,80 $

69904,77%

WuXi Biologics (Cayman) Inc

17,42 $

22691,02%

Innovent Biologics Inc

33,45 $

18013,46%

Ocumension Therapeutics

3,72 $

14772,36%

AIXTRON SE

9,37 CHF

AIXA0,00%

Befesa SA

20,08 €

BFSA1,08%

Metro AG Preference Shares

4,86 €

B4B32,97%

Siltronic AG

43,94 €

WAF0,41%

AktsiaNoteeritud börsil: DEKoduriik: CH

Viimane sulgemishind

40,55 €

Tänane vahemik

39,90 € - 40,60 €

Aasta vahemik

36,90 € - 52,60 €

Turuväärtus

2,11 mld CHF

Keskmine maht

3,37 tuh

P/E suhe

-

Dividendimäär

-

Põhibörs

SWX

Börsiuudised

NASDAQ snaps five-day losing streak with its best day since November 6

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.65%

Nasdaq surges by over 2.4% after December CPI lifts stocks

Goldman Sachs, American Express share gains lead Dow's nearly 750-point rally

Financial Times

Investors pour billions into S&P equal weight fund as tech fears rise

The Business Times

US: Wall St opens higher after inflation data, strong bank earnings

Teave

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Asutatud

9. nov 1993

Peakontor

Küsnacht, Zürich
Šveits

Veebisait

Otsing

Kustuta otsing

Sule otsing

Google'i rakendused

Peamenüü